Article
Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006-2016.
BMC women's health - 29 Jun 2022
Adolph Lauren, Warias Ashley, Stairs Jocelyn, Collins-McNeil Kelly, Penney Lynette, Kieser Katharina
Abstract excerpt
BACKGROUND: Germline pathogenic variants in BRCA1/2 have been established in hereditary breast and ovarian cancer (HBOC) syndrome and result in significantly elevated lifetime risk of ovarian cancer. Risk reduction interventions are presently the only effective means of improving survival and specialized counselling clinics have been established as an effective means of aiding this population in navigating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.